lifestyle.californiaconsumerbanking.com

Author: Tevogen Bio Inc

Letter to Shareholders from CEO Dr. Ryan Saadi

April 30, 2026
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

April 30, 2026
Tevogen Announces Reverse Stock Split

April 30, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

April 29, 2026
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

April 29, 2026
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

January 30, 2026
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue

January 29, 2026